Health Care

Analyst Recent Rating Update: Novavax, Inc. (NASDAQ:NVAX) , Ophthotech Corporation (NASDAQ:OPHT)

0 39

Novavax, Inc. (NASDAQ:NVAX) initiated the shares trading at $1.78 and showed negative change of -8.47% while the stock’s final trade was registered at $ 1.62. However, its previous closing price was seen at $1.77. The stock negotiated total number of 14.83 million shares as compared to 3 months average volume of 16.99 million shares.

The stock price demonstrated downbeat change from its 50 day moving average of 4.42 and had been down from its 200 Day Moving Average of 5.82.

Brokerage Recommendations:

Shares of Novavax, Inc. (NASDAQ:NVAX) declined -8.47% and ended at $1.62 smaller than previous closing price of $1.77. The total 14.83 million shares were bought and sold throughout the most recent trading session less than average volume of 16.99 million shares.

Ophthotech Corporation (NASDAQ:OPHT) initiated the shares trading at $42.24 and showed negative change of -3.42% while the stock’s final trade was registered at $ 40.94. However, its previous closing price was seen at $42.39. The stock negotiated total number of 749.91 thousand shares as compared to 3 months average volume of 666.12 thousand shares.

The stock price demonstrated downbeat change from its 50 day moving average of 52.23 and had been down from its 200 Day Moving Average of 52.17.

Brokerage Recommendations:

Shares of Ophthotech Corporation (NASDAQ:OPHT) declined -3.42% and ended at $40.94 smaller than previous closing price of $42.39. The total 749.91 thousand shares were bought and sold throughout the most recent trading session more than average volume of 666.12 thousand shares.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter